Antibody Responses to SARS-CoV-2 in Coronavirus Diseases 2019 Patients with Different Severity
Ekasit Kowitdamrong, View ORCID ProfileThanyawee Puthanakit, Watsamon Jantarabenjakul, View ORCID ProfileEakachai Prompetchara, Pintip Suchartlikitwong, View ORCID ProfileOpass Putcharoen, View ORCID ProfileNattiya Hirankarn
doi: https://doi.org/10.1101/2020.09.06.20189480
Ekasit Kowitdamrong
1Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
2Applied Medical Virology Research Unit, Chulalongkorn University, Bangkok, Thailand
Thanyawee Puthanakit
3Department of Paediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
4Center of Excellence in Pediatric Infectious Diseases and Vaccines, Chulalongkorn University, Bangkok, Thailand
Watsamon Jantarabenjakul
3Department of Paediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
4Center of Excellence in Pediatric Infectious Diseases and Vaccines, Chulalongkorn University, Bangkok, Thailand
5Thai Red Cross Emerging Infectious Diseases Clinical Centre, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
Eakachai Prompetchara
6Center of Excellence in Vaccine Research and Development (ChulaVRC), Chulalongkorn University, Bangkok, Thailand
7Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Pintip Suchartlikitwong
1Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
4Center of Excellence in Pediatric Infectious Diseases and Vaccines, Chulalongkorn University, Bangkok, Thailand
Opass Putcharoen
5Thai Red Cross Emerging Infectious Diseases Clinical Centre, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
8Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
Nattiya Hirankarn
1Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
9Center of Excellence in Immunology and Immune-mediated Diseases, Chulalongkorn University, Bangkok, Thailand
Article usage
Posted September 08, 2020.
Antibody Responses to SARS-CoV-2 in Coronavirus Diseases 2019 Patients with Different Severity
Ekasit Kowitdamrong, Thanyawee Puthanakit, Watsamon Jantarabenjakul, Eakachai Prompetchara, Pintip Suchartlikitwong, Opass Putcharoen, Nattiya Hirankarn
medRxiv 2020.09.06.20189480; doi: https://doi.org/10.1101/2020.09.06.20189480
Antibody Responses to SARS-CoV-2 in Coronavirus Diseases 2019 Patients with Different Severity
Ekasit Kowitdamrong, Thanyawee Puthanakit, Watsamon Jantarabenjakul, Eakachai Prompetchara, Pintip Suchartlikitwong, Opass Putcharoen, Nattiya Hirankarn
medRxiv 2020.09.06.20189480; doi: https://doi.org/10.1101/2020.09.06.20189480
Subject Area
Subject Areas
- Addiction Medicine (343)
- Allergy and Immunology (666)
- Anesthesia (180)
- Cardiovascular Medicine (2630)
- Dermatology (222)
- Emergency Medicine (397)
- Epidemiology (12183)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4071)
- Geriatric Medicine (387)
- Health Economics (679)
- Health Informatics (2628)
- Health Policy (998)
- Hematology (362)
- HIV/AIDS (845)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (431)
- Neurology (3840)
- Nursing (209)
- Nutrition (571)
- Oncology (2011)
- Ophthalmology (582)
- Orthopedics (239)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (74)
- Pathology (471)
- Pediatrics (1109)
- Primary Care Research (449)
- Public and Global Health (6504)
- Radiology and Imaging (1390)
- Respiratory Medicine (869)
- Rheumatology (401)
- Sports Medicine (341)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)